{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:59:11Z","timestamp":1780880351228,"version":"3.54.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science and technology development project of Shanghai University of Traditional Chinese Medicine","award":["24KFL065"],"award-info":[{"award-number":["24KFL065"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04957-7","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T08:56:09Z","timestamp":1777020969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel LncRNA signature associated with cuproptosis for prognostic prediction and immune response assessment in rectum adenocarcinoma"],"prefix":"10.1007","volume":"17","author":[{"given":"Minghe","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"issue":"1","key":"4957_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA Cancer J Clin"},{"issue":"28","key":"4957_CR2","doi-asserted-by":"publisher","first-page":"4620","DOI":"10.1200\/JCO.2006.06.7629","volume":"24","author":"JP G\u00e9rard","year":"2006","unstructured":"G\u00e9rard JP, Conroy T, Bonnetain F, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in t3-4 rectal cancers: results of ffcd 9203. J Clin Oncol. 2006;24(28):4620\u20135. https:\/\/doi.org\/10.1200\/JCO.2006.06.7629.","journal-title":"J Clin Oncol"},{"issue":"11","key":"4957_CR3","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1056\/NEJMoa060829","volume":"355","author":"JF Bosset","year":"2006","unstructured":"Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med. 2006;355(11):1114\u201323. https:\/\/doi.org\/10.1056\/NEJMoa060829.","journal-title":"N Engl J Med"},{"key":"4957_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cells13030245","author":"PW Underwood","year":"2024","unstructured":"Underwood PW, Ruff SM, Pawlik TM. Update on targeted therapy and immunotherapy for metastatic colorectal cancer. Cells. 2024. https:\/\/doi.org\/10.3390\/cells13030245.","journal-title":"Cells"},{"issue":"3","key":"4957_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrclinonc.2009.237","volume":"7","author":"E Vilar","year":"2010","unstructured":"Vilar E, Gruber SB. Microsatellite instability in colorectal cancer-the stable evidence. Nat Rev Clin Oncol. 2010;7(3):153\u201362. https:\/\/doi.org\/10.1038\/nrclinonc.2009.237.","journal-title":"Nat Rev Clin Oncol"},{"issue":"23","key":"4957_CR6","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","volume":"383","author":"T Andr\u00e9","year":"2020","unstructured":"Andr\u00e9 T, Shiu KK, Kim TW, et al. Pembrolizumab in microsatellite-instability-high advanced colorectal cancer. N Engl J Med. 2020;383(23):2207\u201318. https:\/\/doi.org\/10.1056\/NEJMoa2017699.","journal-title":"N Engl J Med"},{"issue":"10","key":"4957_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101174","volume":"14","author":"Y Xi","year":"2021","unstructured":"Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol. 2021;14(10):101174. https:\/\/doi.org\/10.1016\/j.tranon.2021.101174.","journal-title":"Transl Oncol"},{"issue":"48","key":"4957_CR8","doi-asserted-by":"publisher","first-page":"19507","DOI":"10.1073\/pnas.1318431110","volume":"110","author":"S Ishida","year":"2013","unstructured":"Ishida S, Andreux P, Poitry-Yamate C, Auwerx J, Hanahan D. Bioavailable copper modulates oxidative phosphorylation and growth of tumors. Proc Natl Acad Sci U S A. 2013;110(48):19507\u201312. https:\/\/doi.org\/10.1073\/pnas.1318431110.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4957_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/imr.13276","volume":"321","author":"WQ Liu","year":"2024","unstructured":"Liu WQ, Lin WR, Yan L, Xu WH, Yang J. Copper homeostasis and cuproptosis in cancer immunity and therapy. Immunol Rev. 2024;321(1):211\u201327. https:\/\/doi.org\/10.1111\/imr.13276.","journal-title":"Immunol Rev"},{"issue":"2","key":"4957_CR10","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41568-021-00417-2","volume":"22","author":"EJ Ge","year":"2022","unstructured":"Ge EJ, Bush AI, Casini A, et al. Connecting copper and cancer: from transition metal signalling to metalloplasia. Nat Rev Cancer. 2022;22(2):102\u201313. https:\/\/doi.org\/10.1038\/s41568-021-00417-2.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"4957_CR11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2217\/nnm-2021-0374","volume":"17","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Huo Z, Qi X, Zuo T, Wu Z. Copper-induced tumor cell death mechanisms and antitumor theragnostic applications of copper complexes. Nanomedicine. 2022;17(5):303\u201324. https:\/\/doi.org\/10.2217\/nnm-2021-0374.","journal-title":"Nanomedicine"},{"key":"4957_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.947551","volume":"13","author":"L Yang","year":"2022","unstructured":"Yang L, Yu J, Tao L, et al. Cuproptosis-related lncrnas are biomarkers of prognosis and immune microenvironment in head and neck squamous cell carcinoma. Front Genet. 2022;13:947551. https:\/\/doi.org\/10.3389\/fgene.2022.947551.","journal-title":"Front Genet"},{"issue":"26","key":"4957_CR13","doi-asserted-by":"publisher","first-page":"9922","DOI":"10.1021\/jacs.1c04082","volume":"143","author":"WH Chang","year":"2021","unstructured":"Chang WH, Lin HH, Tsai IK, et al. Copper centers in the cryo-EM structure of particulate methane monooxygenase reveal the catalytic machinery of methane oxidation. J Am Chem Soc. 2021;143(26):9922\u201332. https:\/\/doi.org\/10.1021\/jacs.1c04082.","journal-title":"J Am Chem Soc"},{"issue":"2","key":"4957_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12568","volume":"52","author":"Z Yu","year":"2019","unstructured":"Yu Z, Zhou R, Zhao Y, et al. Blockage of SLC31A1-dependent copper absorption increases pancreatic cancer cell autophagy to resist cell death. Cell Prolif. 2019;52(2):e12568. https:\/\/doi.org\/10.1111\/cpr.12568.","journal-title":"Cell Prolif"},{"issue":"6","key":"4957_CR15","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1021\/acs.jmedchem.8b01996","volume":"62","author":"G Chen","year":"2019","unstructured":"Chen G, Niu C, Yi J, et al. Novel triapine derivative induces copper-dependent cell death in hematopoietic cancers. J Med Chem. 2019;62(6):3107\u201321. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b01996.","journal-title":"J Med Chem"},{"issue":"1","key":"4957_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27559-z","volume":"12","author":"D Ramchandani","year":"2021","unstructured":"Ramchandani D, Berisa M, Tavarez DA, et al. Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis. Nat Commun. 2021;12(1):7311. https:\/\/doi.org\/10.1038\/s41467-021-27559-z.","journal-title":"Nat Commun"},{"key":"4957_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2023.110546","volume":"382","author":"R Geng","year":"2023","unstructured":"Geng R, Ke N, Wang Z, et al. Copper deprivation enhances the chemosensitivity of pancreatic cancer to rapamycin by mtorc1\/2 inhibition. Chem Biol Interact. 2023;382:110546. https:\/\/doi.org\/10.1016\/j.cbi.2023.110546.","journal-title":"Chem Biol Interact"},{"key":"4957_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.598817","volume":"10","author":"N Gao","year":"2020","unstructured":"Gao N, Li Y, Li J, et al. Long non-coding rnas: the regulatory mechanisms, research strategies, and future directions in cancers. Front Oncol. 2020;10:598817. https:\/\/doi.org\/10.3389\/fonc.2020.598817.","journal-title":"Front Oncol"},{"issue":"2","key":"4957_CR19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22(2):96\u2013118. https:\/\/doi.org\/10.1038\/s41580-020-00315-9.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"28","key":"4957_CR20","doi-asserted-by":"publisher","first-page":"44719","DOI":"10.18632\/oncotarget.8089","volume":"7","author":"M Meryet-Figui\u00e8re","year":"2016","unstructured":"Meryet-Figui\u00e8re M, Lambert B, Gauduchon P, et al. An overview of long non-coding rnas in ovarian cancers. Oncotarget. 2016;7(28):44719\u201334. https:\/\/doi.org\/10.18632\/oncotarget.8089.","journal-title":"Oncotarget"},{"issue":"7","key":"4957_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3179","volume":"22","author":"W Ai","year":"2020","unstructured":"Ai W, Li F, Yu HH, Liang ZH, Zhao HP. Up-regulation of long noncoding RNA LINC00858 is associated with poor prognosis in gastric cancer. J Gene Med. 2020;22(7):e3179. https:\/\/doi.org\/10.1002\/jgm.3179.","journal-title":"J Gene Med"},{"key":"4957_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.785839","volume":"12","author":"W Jiang","year":"2021","unstructured":"Jiang W, Song Y, Zhong Z, Gao J, Meng X. Ferroptosis-related long non-coding rna signature contributes to the prediction of prognosis outcomes in head and neck squamous cell carcinomas. Front Genet. 2021;12:785839. https:\/\/doi.org\/10.3389\/fgene.2021.785839.","journal-title":"Front Genet"},{"issue":"27","key":"4957_CR23","doi-asserted-by":"publisher","first-page":"44195","DOI":"10.18632\/oncotarget.17409","volume":"8","author":"M Shi","year":"2017","unstructured":"Shi M, Zhang XY, Yu H, et al. Ddx11-as1 as potential therapy targets for human hepatocellular carcinoma. Oncotarget. 2017;8(27):44195\u2013202. https:\/\/doi.org\/10.18632\/oncotarget.17409.","journal-title":"Oncotarget"},{"issue":"2","key":"4957_CR24","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.18632\/oncotarget.6450","volume":"7","author":"S Gao","year":"2016","unstructured":"Gao S, Wang P, Hua Y, et al. Ror functions as a cerna to regulate nanog expression by sponging mir-145 and predicts poor prognosis in pancreatic cancer. Oncotarget. 2016;7(2):1608\u201318. https:\/\/doi.org\/10.18632\/oncotarget.6450.","journal-title":"Oncotarget"},{"issue":"2","key":"4957_CR25","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.cell.2018.03.042","volume":"173","author":"C Hutter","year":"2018","unstructured":"Hutter C, Zenklusen JC. The Cancer Genome Atlas: creating lasting value beyond its data. Cell. 2018;173(2):283\u20135. https:\/\/doi.org\/10.1016\/j.cell.2018.03.042.","journal-title":"Cell"},{"issue":"1","key":"4957_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17549-y","volume":"11","author":"L Aubert","year":"2020","unstructured":"Aubert L, Nandagopal N, Steinhart Z, et al. Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer. Nat Commun. 2020;11(1):3701. https:\/\/doi.org\/10.1038\/s41467-020-17549-y.","journal-title":"Nat Commun"},{"issue":"6586","key":"4957_CR27","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375(6586):1254\u201361. https:\/\/doi.org\/10.1126\/science.abf0529.","journal-title":"Science"},{"key":"4957_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.101018","volume":"72","author":"Y Wang","year":"2024","unstructured":"Wang Y, Chen Y, Zhang J, et al. Cuproptosis: a novel therapeutic target for overcoming cancer drug resistance. Drug Resist Updat. 2024;72:101018. https:\/\/doi.org\/10.1016\/j.drup.2023.101018.","journal-title":"Drug Resist Updat"},{"issue":"2","key":"4957_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/cac2.12108","volume":"41","author":"YT Tan","year":"2021","unstructured":"Tan YT, Lin JF, Li T, Li JJ, Xu RH, Ju HQ. LNCRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun. 2021;41(2):109\u201320. https:\/\/doi.org\/10.1002\/cac2.12108.","journal-title":"Cancer Commun"},{"issue":"6","key":"4957_CR30","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/1878-0261.12676","volume":"14","author":"Y Ban","year":"2020","unstructured":"Ban Y, Tan P, Cai J, et al. Lncarod is stabilized by m6a methylation and promotes cancer progression via forming a ternary complex with hspa1a and ybx1 in head and neck squamous cell carcinoma. Mol Oncol. 2020;14(6):1282\u201396. https:\/\/doi.org\/10.1002\/1878-0261.12676.","journal-title":"Mol Oncol"},{"issue":"12","key":"4957_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1521","volume":"8","author":"W Liu","year":"2020","unstructured":"Liu W, Zhuang C, Huang T, et al. Loss of cdkn2a at chromosome 9 has a poor clinical prognosis and promotes lung cancer progression. Mol Genet Genomic Med. 2020;8(12):e1521. https:\/\/doi.org\/10.1002\/mgg3.1521.","journal-title":"Mol Genet Genomic Med"},{"issue":"1","key":"4957_CR32","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1186\/s12885-023-11603-w","volume":"23","author":"Y Dong","year":"2023","unstructured":"Dong Y, Zheng M, Wang X, Yu C, Qin T, Shen X. High expression of cdkn2a is associated with poor prognosis in colorectal cancer and may guide pd-1-mediated immunotherapy. BMC Cancer. 2023;23(1):1097. https:\/\/doi.org\/10.1186\/s12885-023-11603-w.","journal-title":"BMC Cancer"},{"key":"4957_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.834235","volume":"12","author":"WK Shi","year":"2022","unstructured":"Shi WK, Li YH, Bai XS, Lin GL. The cell cycle-associated protein cdkn2a may promotes colorectal cancer cell metastasis by inducing epithelial-mesenchymal transition. Front Oncol. 2022;12:834235. https:\/\/doi.org\/10.3389\/fonc.2022.834235.","journal-title":"Front Oncol"},{"issue":"19","key":"4957_CR34","doi-asserted-by":"publisher","first-page":"4910","DOI":"10.1158\/0008-5472.CAN-21-0463","volume":"81","author":"JP Unfried","year":"2021","unstructured":"Unfried JP, Mar\u00edn-Baquero M, Rivera-Calzada \u00c1, et al. Long noncoding rna nihcole promotes ligation efficiency of dna double-strand breaks in hepatocellular carcinoma. Cancer Res. 2021;81(19):4910\u201325. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-0463.","journal-title":"Cancer Res"},{"key":"4957_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101304","volume":"18","author":"SY Xiao","year":"2022","unstructured":"Xiao SY, Yan ZG, Zhu XD, Qiu J, Lu YC, Zeng FR. LncRNA DLGAP1-AS2 promotes the radioresistance of rectal cancer stem cells by upregulating CD151 expression via E2F1. Transl Oncol. 2022;18:101304. https:\/\/doi.org\/10.1016\/j.tranon.2021.101304.","journal-title":"Transl Oncol"},{"issue":"1","key":"4957_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02829-4","volume":"42","author":"Y Chen","year":"2023","unstructured":"Chen Y, Shen H, Liu T, et al. Atr-binding lncrna scarna2 promotes cancer resistance through facilitating efficient dna end resection during homologous recombination repair. J Exp Clin Cancer Res. 2023;42(1):256. https:\/\/doi.org\/10.1186\/s13046-023-02829-4.","journal-title":"J Exp Clin Cancer Res"},{"key":"4957_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.952290","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu H, Tang T. Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set. Front Oncol. 2022;12:952290. https:\/\/doi.org\/10.3389\/fonc.2022.952290.","journal-title":"Front Oncol"},{"issue":"5","key":"4957_CR38","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.celrep.2019.07.001","volume":"28","author":"LA Donehower","year":"2019","unstructured":"Donehower LA, Soussi T, Korkut A, et al. Integrated analysis of tp53 gene and pathway alterations in The Cancer Genome Atlas. Cell Rep. 2019;28(5):1370\u201384. https:\/\/doi.org\/10.1016\/j.celrep.2019.07.001.","journal-title":"Cell Rep"},{"issue":"5","key":"4957_CR39","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.annonc.2021.02.006","volume":"32","author":"DJ Mcgrail","year":"2021","unstructured":"Mcgrail DJ, Pili\u00e9 PG, Rashid NU, et al. High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types. Ann Oncol. 2021;32(5):661\u201372. https:\/\/doi.org\/10.1016\/j.annonc.2021.02.006.","journal-title":"Ann Oncol"},{"key":"4957_CR40","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/583929","volume":"2011","author":"A Mogi","year":"2011","unstructured":"Mogi A, Kuwano H. TP53 mutations in nonsmall cell lung cancer. J Biomed Biotechnol. 2011;2011:583929. https:\/\/doi.org\/10.1155\/2011\/583929.","journal-title":"J Biomed Biotechnol"},{"issue":"2","key":"4957_CR41","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/0391560319899011","volume":"87","author":"S Siracusano","year":"2020","unstructured":"Siracusano S, Rizzetto R, Porcaro AB. Bladder cancer genomics. Urologia. 2020;87(2):49\u201356. https:\/\/doi.org\/10.1177\/0391560319899011.","journal-title":"Urologia"},{"issue":"2","key":"4957_CR42","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41391-020-00302-3","volume":"24","author":"Z Liu","year":"2021","unstructured":"Liu Z, Guo H, Zhu Y, et al. Tp53 alterations of hormone-na\u00efve prostate cancer in the Chinese population. Prostate Cancer Prostatic Dis. 2021;24(2):482\u201391. https:\/\/doi.org\/10.1038\/s41391-020-00302-3.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"13","key":"4957_CR43","doi-asserted-by":"publisher","first-page":"22175","DOI":"10.18632\/oncotarget.14549","volume":"8","author":"L Du","year":"2017","unstructured":"Du L, Kim JJ, Shen J, Chen B, Dai N. KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis. Oncotarget. 2017;8(13):22175\u201386. https:\/\/doi.org\/10.18632\/oncotarget.14549.","journal-title":"Oncotarget"},{"issue":"4","key":"4957_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2022.188738","volume":"1877","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Bu L, Luo J, Guo J. Targeting protein kinases benefits cancer immunotherapy. Biochim Biophys Acta Rev Cancer. 2022;1877(4):188738. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188738.","journal-title":"Biochim Biophys Acta Rev Cancer"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04957-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04957-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04957-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:29:49Z","timestamp":1780878589000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04957-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4957"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04957-7","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors declare their consent to the publication of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"857"}}